Genetic testing company 23andMe’s bankruptcy has led to a new consumer privacy issue: what happens to the DNA of millions of Americans when it goes on sale?
Related Posts
Tariffs, declining real wages, slowing growth: Japan’s central bank has its work cut out
Latest wage data highlights that inflation could be taking a substantial bite out of incomes in Japan, despite incomes in the country rising.
Buy the dip on these credit card giants as stablecoin weakness is overblown, says Wells Fargo
Investors should consider taking advantage of the recent pullback in shares of these two credit card giants, Wells Fargo said on Tuesday.
Baird upgrades this cloud communications stock, calling for around 40% upside
The firm upgraded the cloud communications stock to an outperform from neutral and raised its price target to $160 per share from $115.